I'll research ROL (Rollins Inc.) before writing the preview. Let me gather recent earnings materials, news, and price data.ROL has seen a dramatic decline — from ~$65 in Feb 2026 to ~$44 now, with a sharp drop in late May/early June 2026. Let me investigate what happened and read the most recent earnings materials.The stock's steep decline coincides with a surprise CFO transition announced May 27, 2026. Let me dig into that and the Q1 call, plus look for any other news driving the sell-off.The CFO transition alone seems insufficient to explain a ~20% drop. Let me read the Q1 2026 earnings call for guidance/margin themes and the year-ago Q2 2025 release for comparison, plus check recent news and sector context.Let me check recent news sentiment and whether there was an Investor Day (May 14) that may have affected the stock, plus get the latest 2-week news digest.ROL-specific news is quiet right now. Let me do a quick web search for current analyst sentiment, consensus estimates, and context on the sharp decline, then compute key setup metrics.# Rollins, Inc. (ROL) — Q2 2026 Earnings Preview
A high-quality, defensive compounder that has gotten hit hard. ROL enters this print down roughly 26% year-to-date and ~33% off its February high (~$65.60), closing at $43.87 on July 21, versus an S&P 500 that has continued to grind higher. The stock has meaningfully de-rated — unusual for a recession-resilient pest control name that historically trades at a premium multiple — so this quarter is less about a modest beat/miss and more about whether the growth-and-margin story is still intact under a brand-new CFO.
Two things collided:
A surprise CFO departure. On May 27, 2026, Rollins announced that Kenneth Krause — EVP & CFO since 2022 — would resign effective June 15 to pursue an opportunity in an unrelated industry, with William Harkins (who joined as Chief Accounting Officer in March 2025, prior CAO/Controller at Mohawk Industries) stepping up as CFO. Krause was widely credited with modernizing the finance function, optimizing the capital structure, improving investor transparency, and helping grow market cap ~50%+ since 2022. The stock fell on the news and kept sliding — down ~17.5% from the day before the announcement to today.
A multiple de-rate on a "richly-priced defensive." The bulk of the decline actually built through 1H 2026 as expensive quality/defensive names came out of favor while the broad market rose. Even after the drop, ROL still trades around ~40x trailing adjusted EPS — expensive in absolute terms, but well below the ~55–60x it commanded at the February peak.
Bottom line: Wednesday is the first full quarter narrated by a new CFO into a skeptical tape. Continuity of guidance, tone, and credibility matter as much as the numbers.
This is the single most important line. Management has repeatedly reaffirmed a full-year framework of 7–8% organic growth plus 2–3% from M&A.
My rough model: ~9–11% total growth implies ~$1.09–1.11B in revenue.
Q1 margins disappointed: operating margin fell 120 bps to 16.1% and adjusted EBITDA margin fell 110 bps to 19.8%. Management attributed this to specific, mostly-transitory items and promised sequential improvement into peak season. The Q2 print is the credibility check on that promise. Key drivers to parse:
Watch for incremental margins: management argued Q1's underlying incrementals would have been ~20% ex-insurance/fleet, and reaffirmed the double-digit earnings-growth goal. Investors will want the reported (not adjusted-for-everything) incrementals to finally show up.
My rough model: adjusted EPS around $0.32–0.34 vs. $0.30 a year ago (Q2 2025 GAAP EPS was $0.29).
With Harkins narrating for the first time, listen for: - Whether the full-year 7–8% organic / 2–3% M&A framework is explicitly reaffirmed (any softening will be punished). - Reaffirmation of double-digit adjusted earnings growth and >100% free-cash-flow conversion for 2026. - Any change in cadence, disclosure, or capital-allocation philosophy. Continuity and confidence are the assignment.
Q1 free cash flow fell ~21% to $111M, but on optics: it was hit by ~$40M of tax-payment timing (tax-credit strategy) and ~$9M from the shift to semi-annual interest on the 2035 notes. Management said ex-those items FCF would have grown ~14%, and guided the interest drag to not repeat in Q2. Watch for the normalization they promised, plus: - M&A pace — Romex (a PCT top-40 company) closed in April and should lift the M&A contribution; Q1 M&A added 3.6% to growth. Balance sheet is healthy at 0.9x leverage. - Dividend — raised to $0.1825/quarter (up ~11% y/y); ROL is a serial raiser. - Any commentary on buybacks given the depressed share price (they repurchased ~$22M in Q1).
Bull case: Peak-season volume confirms the March acceleration, organic prints in the 7–8% zone, insurance/fleet headwinds fade and margins re-expand year-over-year, new CFO reaffirms everything, and a ~40x multiple on a de-rated, still-double-digit-earnings-grower starts to look like an entry point after a 33% drawdown.
Bear case: March strength was weather catch-up, the tough Q2 comp bites, insurance/claims stays elevated and margins miss again, and the CFO transition + persistent de-rating signal that a premium defensive multiple simply isn't coming back — leaving the stock stuck even on "fine" fundamentals.
| Metric | Value |
|---|---|
| Last close (7/21/26) | $43.87 |
| YTD | ~ –26% |
| From 2/11 high (~$65.60) | ~ –33% |
| Trailing 12-mo | ~ –21% |
| Since day before CFO news (5/26) | ~ –17.5% |
| 52-wk low (6/30/26) | ~$41.74 |
| Leverage | 0.9x |
| Est. Q2'26 revenue | ~$1.09–1.11B |
| Est. Q2'26 adj. EPS | ~$0.32–0.34 (vs. $0.30 LY) |
| Q2'25 actuals | Rev $999.5M / GAAP EPS $0.29 / Adj EPS $0.30 |
Estimates above are my own back-of-envelope figures derived from the year-ago base and management's growth framework, not published consensus.
Ignore the headline EPS for a second and watch three things on the tape: (1) organic growth by segment vs. the 7–8% goal, (2) whether year-over-year margins turn positive as insurance/fleet headwinds were promised to ease, and (3) whether the new CFO reaffirms the full-year framework word-for-word. Get those three green and the drawdown looks overdone; any wobble and the de-rating likely has further to run.